18229-Myelomas-NA-1244

Myelomas

207495: A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide plus Low-dose Dexamethasone (pom/dex) in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM3)

  • Details

ClinicalTrials.gov ID: NCT04162210
Diagnosis Type: NA
USOR Number:

  • Address

2312 N Nevada Ave, Suite 400
Colorado Springs, CO 80907
P: (719) 577-2555

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.